ZA974869B - Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament comprising them. - Google Patents

Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament comprising them.

Info

Publication number
ZA974869B
ZA974869B ZA9704869A ZA974869A ZA974869B ZA 974869 B ZA974869 B ZA 974869B ZA 9704869 A ZA9704869 A ZA 9704869A ZA 974869 A ZA974869 A ZA 974869A ZA 974869 B ZA974869 B ZA 974869B
Authority
ZA
South Africa
Prior art keywords
medicament
ortho
diagnostic
preparation
substituted benzoylguanidines
Prior art date
Application number
ZA9704869A
Other languages
English (en)
Inventor
Andreas Weichert
Joachim Brendel
Heinz-Werner Kleemann
Hans Jochen Lang
Jan-Robert Schwark
Udo Albus
Wolfgang Scholz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA974869B publication Critical patent/ZA974869B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
ZA9704869A 1996-06-04 1997-06-03 Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament comprising them. ZA974869B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19622370A DE19622370A1 (de) 1996-06-04 1996-06-04 Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
ZA974869B true ZA974869B (en) 1997-12-04

Family

ID=7796095

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704869A ZA974869B (en) 1996-06-04 1997-06-03 Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament comprising them.

Country Status (29)

Country Link
US (1) US6011063A (ja)
EP (1) EP0811610B1 (ja)
JP (1) JP4101904B2 (ja)
KR (1) KR980002019A (ja)
CN (1) CN1064956C (ja)
AR (1) AR008761A1 (ja)
AT (1) ATE209630T1 (ja)
AU (1) AU723665B2 (ja)
BR (1) BR9703440A (ja)
CA (1) CA2206758C (ja)
CZ (1) CZ289411B6 (ja)
DE (2) DE19622370A1 (ja)
DK (1) DK0811610T3 (ja)
ES (1) ES2166487T3 (ja)
HR (1) HRP970304B1 (ja)
HU (1) HUP9700989A3 (ja)
ID (1) ID17038A (ja)
IL (1) IL120988A0 (ja)
MX (1) MX9704094A (ja)
NO (1) NO310188B1 (ja)
NZ (1) NZ314973A (ja)
PL (1) PL185757B1 (ja)
PT (1) PT811610E (ja)
RU (1) RU2214397C2 (ja)
SI (1) SI0811610T1 (ja)
SK (1) SK282628B6 (ja)
TR (1) TR199700453A2 (ja)
TW (1) TW429243B (ja)
ZA (1) ZA974869B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410563B1 (en) 1999-12-22 2002-06-25 Merck Frosst Canada & Co. Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
US6639077B2 (en) 2000-03-23 2003-10-28 Merck Frosst Canada & Co. Tri-aryl-substituted-ethane PDE4 inhibitors
MY123585A (en) 2000-03-23 2006-05-31 Merck Canada Inc Tri-aryl-substituted-ethane pde4 inhibitors.
WO2001090076A1 (en) 2000-05-25 2001-11-29 Merck Frosst Canada & Co. Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
US6740666B2 (en) 2000-12-20 2004-05-25 Merck & Co., Inc. Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
JP4460221B2 (ja) 2001-05-24 2010-05-12 メルク フロスト カナダ リミテツド １−ビアリール−１，８−ナフチリジン−４−オン系ホスホジエステラーゼ−４阻害薬
JO2311B1 (en) 2001-08-29 2005-09-12 ميرك فروست كندا ليمتد Alkyl inhibitors Ariel phosphodiesterase-4
ATE486600T1 (de) 2002-03-12 2010-11-15 Merck Sharp & Dohme Di-aryl-substituierte tetrazol-modulatoren des metabotropen glutamat-rezeptors-5
GB0916163D0 (en) * 2009-09-15 2009-10-28 Shire Llc Prodrugs of guanfacine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE157351T1 (de) * 1993-02-20 1997-09-15 Hoechst Ag Substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament, als inhibitoren des zellulären na+/h+-austauschs oder als diagnostikum sowie sie enthaltendes medikament
DE4318756A1 (de) * 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4422685A1 (de) * 1994-06-29 1996-01-04 Hoechst Ag Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
DE19622370A1 (de) 1997-12-11
EP0811610A1 (de) 1997-12-10
SI0811610T1 (en) 2002-04-30
AU2465097A (en) 1997-12-11
US6011063A (en) 2000-01-04
HRP970304A2 (en) 1998-04-30
NZ314973A (en) 1998-09-24
MX9704094A (es) 1997-12-31
TW429243B (en) 2001-04-11
HRP970304B1 (en) 2002-10-31
CN1175572A (zh) 1998-03-11
HUP9700989A3 (en) 1998-04-28
CZ289411B6 (cs) 2002-01-16
PT811610E (pt) 2002-05-31
KR980002019A (ko) 1998-03-30
IL120988A0 (en) 1997-11-20
CN1064956C (zh) 2001-04-25
ID17038A (id) 1997-12-04
AR008761A1 (es) 2000-02-23
ES2166487T3 (es) 2002-04-16
HUP9700989A2 (en) 1997-12-29
ATE209630T1 (de) 2001-12-15
JPH1067731A (ja) 1998-03-10
NO310188B1 (no) 2001-06-05
JP4101904B2 (ja) 2008-06-18
EP0811610B1 (de) 2001-11-28
NO972527L (no) 1997-12-05
CA2206758C (en) 2007-08-14
SK282628B6 (sk) 2002-10-08
CA2206758A1 (en) 1997-12-04
SK69697A3 (en) 1998-01-14
AU723665B2 (en) 2000-08-31
PL320327A1 (en) 1997-12-08
TR199700453A2 (xx) 1997-12-21
PL185757B1 (pl) 2003-07-31
CZ169697A3 (en) 1997-12-17
DE59705495D1 (de) 2002-01-10
DK0811610T3 (da) 2002-03-25
RU2214397C2 (ru) 2003-10-20
BR9703440A (pt) 1998-09-29
NO972527D0 (no) 1997-06-03
HU9700989D0 (en) 1997-07-28

Similar Documents

Publication Publication Date Title
AU7060896A (en) Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
ZA974665B (en) Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them.
AU4221896A (en) Basically-substituted benzoylguanidines, a process for preparing them, their use as a medicament or diagnostic agent, and a medicament containing them
AU6584696A (en) Substituted benzoylguanidines, a process for their preparation, their use as medicament or diagnostic agent, and medicament comprising them
ZA974869B (en) Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament comprising them.
AU2330095A (en) Ortho-amino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them
ZA966106B (en) 4-flouroalkyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them.
ZA976735B (en) Substituted indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them.
ZA975312B (en) Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them.
AU3900895A (en) Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
ZA974664B (en) Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament oder diagnostic, and medicament containing them.
ZA974607B (en) Bis-ortho-substituted benzoylguanidines, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them.
ZA971815B (en) Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them.
ZA971514B (en) Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them.
AU1265997A (en) Substituted thiophenylalkenylcarboxylic acid guanidides, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them
ZA971814B (en) Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them.
AU5972298A (en) Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
AU1239097A (en) Substituted diaryldicarboxylic acid diguanidides, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them